A citation-based method for searching scientific literature

Amélie Dufaÿ Wojcicki, Hervé Hillaireau, Thais Leite Nascimento, Silvia Arpicco, Myriam Taverna, Sandy Ribes, Mickaël Bourge, Valérie Nicolas, Amélie Bochot, Christine Vauthier, Nicolas Tsapis, Elias Fattal. J Control Release 2012
Times Cited: 70







List of co-cited articles
572 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells.
Claudio Surace, Silvia Arpicco, Amélie Dufaÿ-Wojcicki, Véronique Marsaud, Céline Bouclier, Denis Clay, Luigi Cattel, Jack-Michel Renoir, Elias Fattal. Mol Pharm 2009
97
30

CD44: from adhesion molecules to signalling regulators.
Helmut Ponta, Larry Sherman, Peter A Herrlich. Nat Rev Mol Cell Biol 2003
20



Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
Sebastian Taetz, Amélie Bochot, Claudio Surace, Silvia Arpicco, Jack-Michel Renoir, Ulrich F Schaefer, Véronique Marsaud, Saadia Kerdine-Roemer, Claus-Michael Lehr, Elias Fattal. Oligonucleotides 2009
63
20



Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
Hyun-Jong Cho, Hong Yeol Yoon, Heebeom Koo, Seung-Hak Ko, Jae-Seong Shim, Ju-Hee Lee, Kwangmeyung Kim, Ick Chan Kwon, Dae-Duk Kim. Biomaterials 2011
215
17


Hyaluronic acid-coated liposomes for active targeting of gemcitabine.
Silvia Arpicco, Carlotta Lerda, Elisa Dalla Pozza, Chiara Costanzo, Nicolas Tsapis, Barbara Stella, Massimo Donadelli, Ilaria Dando, Elias Fattal, Luigi Cattel,[...]. Eur J Pharm Biopharm 2013
92
15

Hyaluronic acid for anticancer drug and nucleic acid delivery.
Franco Dosio, Silvia Arpicco, Barbara Stella, Elias Fattal. Adv Drug Deliv Rev 2016
279
15


Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.
Shoshy Mizrahy, Sabina Rebe Raz, Martin Hasgaard, Hong Liu, Neta Soffer-Tsur, Keren Cohen, Ram Dvash, Dalit Landsman-Milo, Maria G E G Bremer, S Moein Moghimi,[...]. J Control Release 2011
157
14

Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery.
Ju-Hwan Park, Hyun-Jong Cho, Hong Yeol Yoon, In-Soo Yoon, Seung-Hak Ko, Jae-Seong Shim, Jee-Hyun Cho, Jae Hyung Park, Kwangmeyung Kim, Ick Chan Kwon,[...]. J Control Release 2014
120
14

Hyaluronan binding by cell surface CD44.
J Lesley, V C Hascall, M Tammi, R Hyman. J Biol Chem 2000
313
12

Hyaluronan.
T C Laurent, J R Fraser. FASEB J 1992
12

Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.
Xiao-Yan Yang, Yun-Xia Li, Min Li, Li Zhang, Li-Xia Feng, Na Zhang. Cancer Lett 2013
139
12

Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells.
Silvia Arpicco, Giuseppe De Rosa, Elias Fattal. J Drug Deliv 2013
42
21

Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity.
Elisa Dalla Pozza, Carlotta Lerda, Chiara Costanzo, Massimo Donadelli, Ilaria Dando, Elisa Zoratti, Maria Teresa Scupoli, Stefania Beghelli, Aldo Scarpa, Elias Fattal,[...]. Biochim Biophys Acta 2013
52
17

A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases.
Paola Stephanie Apaolaza, Diego Delgado, Ana del Pozo-Rodríguez, Alicia Rodríguez Gascón, M Ángeles Solinís. Int J Pharm 2014
58
15

Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy.
Thomas F Martens, Katrien Remaut, Hendrik Deschout, Johan F J Engbersen, Wim E Hennink, Mies J van Steenbergen, Jo Demeester, Stefaan C De Smedt, Kevin Braeckmans. J Control Release 2015
89
12

CD44: structure, function, and association with the malignant process.
D Naor, R V Sionov, D Ish-Shalom. Adv Cancer Res 1997
730
11

CD44 in cancer.
David Naor, Shlomo Nedvetzki, Itshak Golan, Lora Melnik, Yoram Faitelson. Crit Rev Clin Lab Sci 2002
398
11

Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin.
Lipeng Qiu, Zhen Li, Mingxi Qiao, Miaomiao Long, Mingyue Wang, Xiaojun Zhang, Chenmin Tian, Dawei Chen. Acta Biomater 2014
102
11

A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells.
Y Luo, M R Ziebell, G D Prestwich. Biomacromolecules 2000
175
11

Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Yanhua Liu, Jin Sun, Wen Cao, Jianhong Yang, He Lian, Xin Li, Yinghua Sun, Yongjun Wang, Siling Wang, Zhonggui He. Int J Pharm 2011
135
11

HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer.
Antonio Rosato, Alessandra Banzato, Gilda De Luca, Davide Renier, Fabio Bettella, Claudio Pagano, Giovanni Esposito, Paola Zanovello, PierFrancesco Bassi. Urol Oncol 2006
62
12

Hyaluronan-CD44 interactions as potential targets for cancer therapy.
Suniti Misra, Paraskevi Heldin, Vincent C Hascall, Nikos K Karamanos, Spyros S Skandalis, Roger R Markwald, Shibnath Ghatak. FEBS J 2011
320
11


Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives.
Eun Ju Oh, Kitae Park, Ki Su Kim, Jiseok Kim, Jeong-A Yang, Ji-Hyun Kong, Min Young Lee, Allan S Hoffman, Sei Kwang Hahn. J Control Release 2010
338
11

Supramolecular Organization and siRNA Binding of Hyaluronic Acid-Coated Lipoplexes for Targeted Delivery to the CD44 Receptor.
Thais L Nascimento, Hervé Hillaireau, Magali Noiray, Claudie Bourgaux, Silvia Arpicco, Gérard Pehau-Arnaudet, Myriam Taverna, Donato Cosco, Nicolas Tsapis, Elias Fattal. Langmuir 2015
28
28


Hyaluronan-modified core-shell liponanoparticles targeting CD44-positive retinal pigment epithelium cells via intravitreal injection.
Li Gan, Jing Wang, Yanan Zhao, Dan Chen, Chunliu Zhu, Jianping Liu, Yong Gan. Biomaterials 2013
59
11

Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activity.
K Akima, H Ito, Y Iwata, K Matsuo, N Watari, M Yanagi, H Hagi, K Oshima, A Yagita, Y Atomi,[...]. J Drug Target 1996
53
13


Involvement of CD44, a molecule with a thousand faces, in cancer dissemination.
David Naor, Shulamit B Wallach-Dayan, Muayad A Zahalka, Ronit Vogt Sionov. Semin Cancer Biol 2008
224
10

Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors.
Ilia Rivkin, Keren Cohen, Jacob Koffler, Dina Melikhov, Dan Peer, Rimona Margalit. Biomaterials 2010
98
8


The liberation of CD44.
Joanna Cichy, Ellen Puré. J Cell Biol 2003
192
8

Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers.
Gideon Bachar, Keren Cohen, Roy Hod, Raphael Feinmesser, Aviram Mizrachi, Thomas Shpitzer, Odelia Katz, Dan Peer. Biomaterials 2011
45
13

CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis.
Annalucia Serafino, Manuela Zonfrillo, Federica Andreola, Rossana Psaila, Luana Mercuri, Noemi Moroni, Davide Renier, Monica Campisi, Cynthia Secchieri, Pasquale Pierimarchi. Curr Cancer Drug Targets 2011
42
14


Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.
Shanthi Ganesh, Arun K Iyer, David V Morrissey, Mansoor M Amiji. Biomaterials 2013
218
8


Hyaluronan is a key component in cryoprotection and formulation of targeted unilamellar liposomes.
Dan Peer, Anat Florentin, Rimona Margalit. Biochim Biophys Acta 2003
61
8

Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin.
Hyun-Jong Cho, In-Soo Yoon, Hong Yeol Yoon, Heebeom Koo, Yu-Jin Jin, Seung-Hak Ko, Jae-Seong Shim, Kwangmeyung Kim, Ick Chan Kwon, Dae-Duk Kim. Biomaterials 2012
170
7

CD44, a therapeutic target for metastasising tumours.
Véronique Orian-Rousseau. Eur J Cancer 2010
344
7

Polysaccharide-based nucleic acid nanoformulations.
Koen Raemdonck, Thomas F Martens, Kevin Braeckmans, Jo Demeester, Stefaan C De Smedt. Adv Drug Deliv Rev 2013
101
7


Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway.
Diego Delgado, Ana del Pozo-Rodríguez, Maria Ángeles Solinís, Alicia Rodríguez-Gascón. Eur J Pharm Biopharm 2011
73
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.